Predicting outcome in hematological stem cell transplantation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 50, Issue 6, 2002, Pages 371-378

  Dickinson, Anne M ^a   Cavet, James ^b   Cullup, Hannah ^a   Wang, Xiao N ^a   Jarvis, Mark ^a   Sviland, Lisbet ^b   Middleton, Peter G ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

An in vitro human skin explant model; Cytokine gene polymorphisms; Predicting GvHD

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

GENETIC POLYMORPHISM; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAVES DISEASE; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; OUTCOMES RESEARCH; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

CYTOKINES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; POLYMORPHISM, GENETIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0036947586     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. ABHYANKAR S., GILLILAND D. G. and FERRARA J. L. (1997): Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens. Transplantation, 56, 1518-1523.
2. ASDERAKIS A., SANKARAN D., DYER P., JOHNSON R. W., PAVICA V., SINNOTT P. J., ROBERTS I. and HUTCHINSON I. V. (2001): Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation, 71, 674-677.
3. AWAD M., PRAVICA V., PERREY C., EL GAMEL A., YONAN N., SINNOTT P. J. and HUTCHINSON I. V. (1999): CA repeat allele polymorphism in the first intron of the human interferon-γ gene is associated with lung allograft fibrosis. Hum. Immunol., 60, 343-346.
4. AWATA T., MATSUMOTO C., URAKAMI T., HAGURA R., AMEMIYA S. and KANAZAWA Y. (1994): Association of polymorphisms in the interferon-γ gene with IDDM. Diabetologica, 37, 1159-1162.
5. BENSINGER W. I., MARTIN P. J., STORER B., CLIFT R., FORMAN S. J., NEGRIN R., KASHYAP A., FLOWERS M. E., LILLEBY K., CHAUNCEY T. R., STORB R. and APPELBAUM F. R. (2001): Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N. Engl. J. Med., 344, 175-181.
6. BIDWELL J. L., WOOD N. A., MORSE H. R., OLOMOLAIYE O. O., KEEN L. J. and LAUNDY G. J. (1999): Human cytokine gene nucleotide sequence alignments: supplement 1. Eur. J. Immunogenet., 26, 135-223.
7. BIDWELL J. L., WOOD N. A., MORSE H. R., OLOMOLAIYE O. O. and LAUNDY G. J. (1998): Human cytokine gene nucleotide sequence alignments 1998. Eur. J. Immunogenet., 25, 83-265.
8. BLAKEMORE A. I., TARLOW J. K., CORK M. J., GORDON C., EMERY P. and DUFF G. W. (1994): Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum., 37, 1380-1385.
9. CAVET J., DICKINSON A. M., NORDEN J., TAYLOR P. R. A., JACKSON G. H. and MIDDLETON P. G. (2001): Interferon-γ and interleukin-6 gene polymorphisms associate with graft versus host disease in HLA-matched sibling bone marrow transplantation. Blood, 98, 1594-1600.
10. CAVET J., MIDDLETON P. G., SEGALL M., NOREEN H., DAVIES S. M. and DICKINSON A. M. (1999): Recipient tumour necrosis factor-α and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood, 94, 3941-3946.
11. COHEN J. (1988): Cytokines as mediators of graft-versus-host disease. Bone Marrow Transplant., 3, 193-197.
12. CULLUP H., WANG X. N., SVlLAND L. and DICKINSON A. M. (2002): Association of interleukin-1 levels with severity of in vitro graft-versus-host reactions as measured by the use of a human skin explant assay (abstract). Bone Marrow Transplant., 29, S171.
13. DICKINSON A. M., HROMADNÍKOVA I., SVILAND L., JACKSON G. H., TAYLOR P. R. A., VAVRINEC J., SEDLACEK P., CERMAKOVA M., STARÝ J., VÍTEK A., SAJDOVA J. and PROCTOR S. J. (1999): Use of a skin explant model for predicting GvHD in HLA-matched bone marrow transplants - effect of GvHD GVHD prophylaxis. Bone Marrow Transplant., 24, 857-863.
14. DICKINSON A. M., WANG X. N., SVILAND L., VYTH-DREESE F. A., JACKSON G. H., SCHUMACHER T. N. M., HAANEN J. B. A. G., MUTIS T. and GOULMY E. (2001): In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat. Med., 8, 410-414.
15. EDWARDS-SMITH C. J., JONSSON J. R., PURDIE D. M., BANSAL A., SHORTHOUSE C. and POWELL E. E. (1999): Interleukin-10 promotor polymorphism predicts initial response of hepatitis C to interferon α. Hepatology, 30, 526-530.
16. ESKDALE J., WORDSWORTH P., BOWMAN S., FIELD M. and GALLAGHER G. (1997): Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens, 49, 635-637.
17. FERRARA J. L. and KRENGER W. (1998): Graft-versus-host disease: the influence of type 1 and type 2 cell cytokines. Transfus. Med. Rev., 12, 1-17.
18. FISHMAN D., FAULDS G., JEFFRY R., MOHAMED-ALI V., YUDKIN J. S., HUMPHRIES S. and WOO P. (1998): The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest., 102, 1369-1367.
19. FLOWERS M. E., KANSU E. and SULLIVAN K. M. (1999): Pathophysiology and treatment of graft-versus-host disease. Hematol. Oncol. Clin. North Am., 13, 1091-1112.
20. FONG K. Y., HOWE H. S., TIN S. K., BOEY M. L. and FENG P. H. (1996): Polymorphism of the regulatory region of tumour necrosis factor α gene in patients with systemic lupus erythematosus. Ann. Acad. Med. Singapore, 25, 22-30.
21. GOKER H., HAZNEDAROGLU I. C. and CHAO N. J. (2001): Acute graft-vs-host disease: pathobiology and management. Exp. Haematol., 29, 259-277.
22. HATTORI H., MATSUZAKI A., SUMINOE A., IHARA K., NAGATOSHI Y., SAKATA N., KAWA K., OKAMURA J. and HARA T. (2000): Polymorphisms of TGF-β1 and TGF-β1 type 2 receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation (abstract). Blood, 96, 396a.
23. HOLLER E., ERTL B., HINTERMEIER-KNABE R., RONCAROLO M.-G., EISSNER F., MAYER F., FRAUNBERGER P., BEHRENDS U., PFANNES W., KOLB H. J. and WILMANNS W. (1997): Inflammatory reactions induced by pretransplant conditioning - an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation? (review). Leuk. Lymphoma, 25, 217-224.
24. HOLLER E., KOLB H. J., HINTERMEIER-KNABE R., MITTERMÜLLER J., THIERFELDE S., KAUL M. and WILMANNS W. (1993): The role of tumor necrosis factor α in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant. Proc., 25, 1234-1236.
25. HOLLER E., KOLB H. J., MITTERMÜLLER J., KAUL M., LEDDEROSE G., DUELL T., SEEBER B., SCHLEUNING M., HINTER-MEIER-KNABE R., ERTL B., KEMPENI J. and WILMANNS W. (1995): Modulation of acute GvHD after allogeneic bone marrow transplantation by TNF-α release in the course of pretransplant conditioning: Role of conditioning regimens and prophylactic application of monoclonal antibody neutralizing human TNF-α (MAK195F). Blood, 86, 890-899.
26. HOLLER E., KOLB H. J., MÖLLER A., KEMPENI J., LIESENFELD S., PECHUMER H., LEHMACHER W., RUCKDESCHEL G., GLEIXNER B., RIEDNER C., LEDDEROSE G., BREHM G., MITTERMÜLLER J. and WILMANNS W. (1990): Increased serum levels of tumour necrosis factor α precede major complications of bone marrow transplantation. Blood, 75, 1011-1016.
27. HOLLER E., RONCAROLO M.-G., HINTERMEIER-KNABE R., EISSNER G., ERTL B., SCHULZ U., KNABE H., KOLB H. J., ANDREESEN R. and WILMANNS W. (2000): Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant., 25, 237-241.
28. HROMADNÍKOVÁ I., SEDLACEK P., STARÝ J., CERMÁKOVÁ M., VAVRINEC J., STECHOVA K., DOLEZALOVA L., SVILAND L. and DICKINSON A. M. (2001): An in vitro skin explant assay as a predictive assay for graft-versus-host disease in a cohort of pediatric transplants. Pediatr. Transplant., 5, 258-265.
29. JASINSKI M., WIECKIEWICZ J., RUGGIERO I., PITUCH-NOWOROLSKA A. and ZEMBELA M. (1995): Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor. J. Clin. Immunol., 15, 185-193.
30. KEEN R. W., WOODFORD-RICHENS K. L., LANCHBURY J. S. and SPECTOR T. D. (1998): Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone, 23, 367-371.
31. KIM T. G., KIM H. Y., LEE S. H., CHO C. S., PARK S. H., CHOI H. B., HAN H. and KIM D. J. (1996): Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum. Immunol., 46, 10-17.
32. KRENGER W. and FERRARA J. L. (1996): Dysregulation of cytokines during graft-versus-host disease. J. Hematother., 5, 3-14.
33. KRENGER W., HILL G. R. and FERRARA J. L. (1997): Cytokine cascades in acute graft-versus-host disease (review). Transplantation, 64, 553-558.
34. LANGE A., KLIMCZAK A., KARABON L. and SUCHNICKI K. (1991): Cytokines, adhesion molecules (E-selectin and VCAM-1) and graft-versus-host disease. Arch. Immunol. Ther. Exp., 43, 99-105.
35. LIN M.-T., MARTIN P. J., TSENG L.-H., GOOLEY T., SINGLETON K. L., MARTIN E. G., PETERSDORF E. W. and HANSEN J. A. (2000): Correlation between polymorphisms of the IL-1 gene complex and development of acute graft-versus-host disease after haematopoietic cell transplantation (abstract). Blood, 96, 396a.
36. LINKER-ISRAELI M., WALLACE D. J., PREHN J., MICHAEL D., HONDA M., TAYLOR K. D., PAUL-LABRADOR M., FISCHEL-GHODSIAN N., FRASER P. A. and KLINENBERG J. R. (1999): Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun., 1, 45-52.
37. LOUIS E., SATSANGI J., ROUSSOMOUSTAKAKI M., PARKES M., FANNING G., WELSH K. and JEWELL D. (1996): Cytokine gene polymorphisms in inflammatory bowel disease. Gut, 39, 705-710.
38. MARSHALL S. E., MCLAREN A. J., MCKINNEY E. F., BIRD T. G., HALDAR N. A., BUNCE M., MORRIS P. J. and WELSH K. I. (2001): Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation, 71, 469-476.
39. MIDDLETON P. G., CULLUP H., DICKINSON A. M., NORDEN J., JACKSON G. H., TAYLOR P. R. A. and CAVET J. (2002): Vitamin D receptor gene polymorphism associates with graft versus host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant (in press).
40. MIDDLETON P. G., TAYLOR P. R. A., JACKSON G., PROCTOR S. J. and DICKINSON A. M. (1998): Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood, 92, 3943-3948.
41. MIDDLETON P. G., WOOD N, DICKINSON A. M., HROMADNÍKO VÁ I. and KEEN L. J. (2002): Ethnic differences in the haplotype distribution of IL-10 genes in the human population. Transplantation (submitted).
42. MURRAY R. E., MCGUIGAN F., GRANT S. F., REID D. M. and RALSTON S. H. (1997): Polymorphisms of the inerleukin-6 are associated with bone mineral density. Bone, 21, 92.
43. POCIOT F., RONNINGEN K. S., BERGHOLDT R., LORENZEN T., JOHANESEN J., YE K., DINARELLO C. A. and NERUP J. (1994): Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes - evidence for polygenicity in man. Autoimmunity, 19, 169-178.
44. PRAVICA V., ASDERAKIS A., PERREY C., HAJEER A., SINNOTT P. and HUTCHINSON I. V. (1999): In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur. J. Immunogenet., 26, 1-3.
45. RICHARD S., SEIGNEUR M., BLANN A., ADAMS R., RENARD M., PUNTOUS M., BOIRON J. M., AMIRAL J., REIFFERS J. and BOISSEAU M. (1996): Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant., 18, 955-959.
46. RINGDÉN O. and DEEG H. J. (1997): Clinical spectrum of graft-versus-host disease. In FERRARA J. L. M., DEEG H. J. and BURAKOFF S. J.: Graft-vs.-host disease. M. Dekker Inc., New York, 525.
47. SANKARAN D., ASDERAKIS A., ASHRAF S., ROBERTS I. S., SHORT C. D., DYER P. A., SINNOTT P. J. and HUTCHINSON I. V. (1999): Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int., 56, 281-288.
48. SANTTILA S., SAVINAINEN K. and HURME M. (1998): Presence of the IL-1Ra allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand. J. Immunol., 47, 195-198.
49. SHLOMCHIK W. D., COUZENS M. S., TANG C. B., MCNIFF J., ROBERT M. E., LIu J., SHLOMCHIK M. J. and EMERSON S. G. (1999): Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, 412-415.
50. SIEGMUND T., USADEL K. H., DONNER H., BRAUN J., WALFISH P. G. and BADENHOOP K. (1998): Interferon-γ gene microsatellite polymorphisms in patients with Graves' disease. Thyroid, 8, 1013-1017.
51. SOCIÉ G., LOISEAU P., TAMOUZA R., BUSSON M., CHARRON D. and GLUCKMAN E. (1999): Risk factors of acute graft-versus-host disease (GvHD): IL-10 polymorphisms and mismatches of minor histocompatibility antigens are independent risk factors (abstract). Blood, 94, 639a.
52. SOCIÉ G., LOISEAU P., TAMOUZA R., JANIN A., BUSSON M., GLUCKMAN E. and CHARRON D. (2001): Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation, 72, 699-705.
53. SULLIVAN K. E., WOOTEN C., SCHMEKPEPER B. J., GOLDMAN D. and PETRI M. A. (1997): A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum., 40, 2207-2211.
54. SVILAND L. and DICKINSON A. M. (1999): A human skin explant model for predicting graft versus host disease following bone marrow transplantation. J. Clin. Pathol., 52, 910-913.
55. TAKAHASHI H., FURUKAWA T., HASHIMOTO S., SUZUKI N., KUROHA T., YAMAZAKI F., INANO K., TAKAHASHI M., AIZAWA Y. and KOIKE T. (2000): Contribution of TNF-α and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant., 26, 1317-1323.
56. TANAKA J., IMAMURA M., KASAI M., HASHINO S., KOBAYASHI S., NOTO S., HIGA T., SAKURADA K. and ASAKA M. (1997): The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transplant., 19, 571-576.
57. TESHIMA T., ORDEMANN R., REDDY P., GAGIN S., LIU C., COOKE K. R. and FERRARA J. L. M. (2002): Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med., 8, 575-581.
58. TURNER D. M., GRANT S. C. D., LAMB W. R., BRENCHLEY P. E. C., DYER P. A., SINNOTT P. J. and HUTCHINSON I. V. (1995): A genetic marker of high TNF-α production in heart transplant recipients. Transplantation, 60, 1113-1117.
59. TURNER D., GRANT S. C., YONAN N. SHELDON S. DYER P. A. SINNOTT P. J. and HUTCHINSON I. V. (1997): Cytokine gene polymorphism and heart transplant rejection. Transplantation, 64, 776-779.
60. TURNER D. M., WlLLIAMS D. M., SANKARAN D., LAZARUS M., SINNOTT P. J. and HUTCHINSON I. V. (1997): An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet., 24, 1-8.
61. VOGELSANG G. B., HESS A. D., BERKMAN A. W., TUTSCHKA P. J., FARMER E. R., CONVERSE P. J. and SANTOS G. W. (1985): An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N. Engl. J. Med., 313, 645-650.
62. XUN Q. C., THOMPSON S. J., JENNINGS C. D., BROWN S. A. and WIDMER M. B. (1994): Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood, 83, 2360-2367.